Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178402802> ?p ?o ?g. }
- W3178402802 abstract "Abstract Triple negative breast cancer holds a dismal clinical outcome and as such, patients routinely undergo aggressive, highly toxic treatment regimens. Clinical trials for TNBC employing immune checkpoint blockade in combination with chemotherapy show modest prognostic benefit, but the percentage of patients that respond to treatment is low, and patients often succumb to relapsed disease. Here, we show that a combination immunotherapy platform utilizing low dose chemotherapy (FEC) combined with oncolytic virotherapy (oHSV-1) increases tumor-infiltrating lymphocytes, in otherwise immune-bare tumors, allowing 60% of mice to achieve durable tumor regression when treated with immune checkpoint blockade. Whole-tumor RNA sequencing of mice treated with FEC + oHSV-1 shows an upregulation of B cell receptor signaling pathways and depletion of B cells prior to the start of treatment in mice results in complete loss of therapeutic efficacy and expansion of myeloid-derived suppressor cells. Additionally, RNA sequencing data shows that FEC + oHSV-1 suppresses genes associated with myeloid-derived suppressor cells, a key population of cells that drive immune escape and mediate therapeutic resistance. These findings highlight the importance of tumor-infiltrating B cells as drivers of antitumor immunity and their potential role in the regulation of myeloid-derived suppressor cells." @default.
- W3178402802 created "2021-07-19" @default.
- W3178402802 creator A5006267566 @default.
- W3178402802 creator A5013043753 @default.
- W3178402802 creator A5044898944 @default.
- W3178402802 creator A5055020606 @default.
- W3178402802 creator A5055462361 @default.
- W3178402802 creator A5055795354 @default.
- W3178402802 creator A5057272813 @default.
- W3178402802 creator A5058837420 @default.
- W3178402802 creator A5066165449 @default.
- W3178402802 creator A5067535356 @default.
- W3178402802 creator A5078849862 @default.
- W3178402802 creator A5085890841 @default.
- W3178402802 creator A5088615358 @default.
- W3178402802 date "2021-07-12" @default.
- W3178402802 modified "2023-10-01" @default.
- W3178402802 title "Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells" @default.
- W3178402802 cites W1962147066 @default.
- W3178402802 cites W1977179270 @default.
- W3178402802 cites W1981343305 @default.
- W3178402802 cites W1981667867 @default.
- W3178402802 cites W1987468883 @default.
- W3178402802 cites W2012522456 @default.
- W3178402802 cites W2020158018 @default.
- W3178402802 cites W2020518300 @default.
- W3178402802 cites W2024397742 @default.
- W3178402802 cites W2025953324 @default.
- W3178402802 cites W2028895853 @default.
- W3178402802 cites W2030317951 @default.
- W3178402802 cites W2038918212 @default.
- W3178402802 cites W2051250007 @default.
- W3178402802 cites W2051998002 @default.
- W3178402802 cites W2059248274 @default.
- W3178402802 cites W2059492353 @default.
- W3178402802 cites W2079068389 @default.
- W3178402802 cites W2084770174 @default.
- W3178402802 cites W2085934079 @default.
- W3178402802 cites W2086837512 @default.
- W3178402802 cites W2092435554 @default.
- W3178402802 cites W2099432296 @default.
- W3178402802 cites W2100545466 @default.
- W3178402802 cites W2102278945 @default.
- W3178402802 cites W2107018762 @default.
- W3178402802 cites W2107665951 @default.
- W3178402802 cites W2110065044 @default.
- W3178402802 cites W2111063688 @default.
- W3178402802 cites W2112825838 @default.
- W3178402802 cites W2114104545 @default.
- W3178402802 cites W2116522697 @default.
- W3178402802 cites W2118440235 @default.
- W3178402802 cites W2122403898 @default.
- W3178402802 cites W2126194508 @default.
- W3178402802 cites W2128976658 @default.
- W3178402802 cites W2130116522 @default.
- W3178402802 cites W2134526812 @default.
- W3178402802 cites W2137526110 @default.
- W3178402802 cites W2139640503 @default.
- W3178402802 cites W2146512944 @default.
- W3178402802 cites W2163035374 @default.
- W3178402802 cites W2163494047 @default.
- W3178402802 cites W2163739312 @default.
- W3178402802 cites W2170903004 @default.
- W3178402802 cites W2189073727 @default.
- W3178402802 cites W2210453860 @default.
- W3178402802 cites W2221450513 @default.
- W3178402802 cites W2344131021 @default.
- W3178402802 cites W2470898142 @default.
- W3178402802 cites W2471500324 @default.
- W3178402802 cites W2473549004 @default.
- W3178402802 cites W2497875668 @default.
- W3178402802 cites W2520500352 @default.
- W3178402802 cites W2520771124 @default.
- W3178402802 cites W2587364318 @default.
- W3178402802 cites W2604805073 @default.
- W3178402802 cites W2732589699 @default.
- W3178402802 cites W2781499826 @default.
- W3178402802 cites W2782817020 @default.
- W3178402802 cites W2789818264 @default.
- W3178402802 cites W2792369984 @default.
- W3178402802 cites W2806911036 @default.
- W3178402802 cites W2888914413 @default.
- W3178402802 cites W2897422388 @default.
- W3178402802 cites W2898558185 @default.
- W3178402802 cites W2899761021 @default.
- W3178402802 cites W2904382186 @default.
- W3178402802 cites W2917427311 @default.
- W3178402802 cites W2918546246 @default.
- W3178402802 cites W2931658275 @default.
- W3178402802 cites W2933024894 @default.
- W3178402802 cites W2941467331 @default.
- W3178402802 cites W2947480481 @default.
- W3178402802 cites W2957660178 @default.
- W3178402802 cites W2967036220 @default.
- W3178402802 cites W2967339341 @default.
- W3178402802 cites W2977541977 @default.
- W3178402802 cites W2998795792 @default.
- W3178402802 cites W3000282923 @default.
- W3178402802 cites W3000311037 @default.
- W3178402802 cites W3000373442 @default.